These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31718300)

  • 1. Preparation of a nanovaccine against
    Maleki M; Salouti M; Shafiee Ardestani M; Talebzadeh A
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):4248-4256. PubMed ID: 31718300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization effect of lipopolysaccharide antigen in conjugation with PLGA nanoparticles as a nanovaccine against Brucella melitensis infection.
    Maleki M; Salouti M
    Biologicals; 2021 Jul; 72():10-17. PubMed ID: 34167853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of two new nanovaccines against Pseudomonas aeruginosa based on LPS and OPS: A comparison study.
    Maleki M; Azimi S; Salouti M
    Immunobiology; 2022 Nov; 227(6):152278. PubMed ID: 36115097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Multiepitope Peptide, rOmp22, Encapsulated in Chitosan-PLGA Nanoparticles as a Candidate Vaccine Against
    Du X; Xue J; Jiang M; Lin S; Huang Y; Deng K; Shu L; Xu H; Li Z; Yao J; Chen S; Shen Z; Feng G
    Int J Nanomedicine; 2021; 16():1819-1836. PubMed ID: 33707942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chlamydia trachomatis recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper 1 cellular and antibody immune responses in mice: a desirable candidate nanovaccine.
    Fairley SJ; Singh SR; Yilma AN; Waffo AB; Subbarayan P; Dixit S; Taha MA; Cambridge CD; Dennis VA
    Int J Nanomedicine; 2013; 8():2085-99. PubMed ID: 23785233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survey of Omp19 immunogenicity against Brucella abortus and Brucella melitensis: influence of nanoparticulation versus traditional immunization.
    Abkar M; Lotfi AS; Amani J; Eskandari K; Ramandi MF; Salimian J; Brujeni GN; Alamian S; Kamali M; Koushki H
    Vet Res Commun; 2015 Dec; 39(4):217-28. PubMed ID: 26395469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective Potential of Conjugated P. aeruginosa LPS -PLGA Nanoparticles in Mice as a Nanovaccine.
    Safari Zanjani L; Shapoury R; Dezfulian M; Mahdavi M; Shafieeardestani M
    Iran J Immunol; 2020 Mar; 17(1):75-86. PubMed ID: 32224543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison between adjuvant and delivering functions of calcium phosphate, aluminum hydroxide and chitosan nanoparticles, using a model protein of Brucella melitensis Omp31.
    Abkar M; Alamian S; Sattarahmady N
    Immunol Lett; 2019 Mar; 207():28-35. PubMed ID: 30707922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PLGA (85:15) nanoparticle based delivery of rL7/L12 ribosomal protein in mice protects against Brucella abortus 544 infection: A promising alternate to traditional adjuvants.
    Singh D; Somani VK; Aggarwal S; Bhatnagar R
    Mol Immunol; 2015 Dec; 68(2 Pt A):272-9. PubMed ID: 26442664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of immune responses induced by polymeric OMP25-BLS Brucella antigen.
    Yousefi S; Abbassi-Daloii T; Sekhavati MH; Tahmoorespur M
    Microb Pathog; 2018 Feb; 115():50-56. PubMed ID: 29253594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The recombinant Omp31 from Brucella melitensis alone or associated with rough lipopolysaccharide induces protection against Brucella ovis infection in BALB/c mice.
    Estein SM; Cassataro J; Vizcaíno N; Zygmunt MS; Cloeckaert A; Bowden RA
    Microbes Infect; 2003 Feb; 5(2):85-93. PubMed ID: 12650766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved serodiagnosis of bovine brucellosis by novel synthetic oligosaccharide antigens representing the capping m epitope elements of Brucella O-polysaccharide.
    McGiven J; Howells L; Duncombe L; Stack J; Ganesh NV; Guiard J; Bundle DR
    J Clin Microbiol; 2015 Apr; 53(4):1204-10. PubMed ID: 25653412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A repA-based ELISA for discriminating cattle vaccinated with Brucella suis 2 from those naturally infected with Brucella abortus and Brucella melitensis.
    Wang JY; Wu N; Liu WH; Ren JJ; Tang P; Qiu YH; Wang CY; Chang CD; Liu HJ
    Mol Cell Probes; 2014; 28(5-6):251-4. PubMed ID: 24941369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cationic polymer modified PLGA nanoparticles encapsulating Alhagi honey polysaccharides as a vaccine delivery system for ovalbumin to improve immune responses.
    Wusiman A; Gu P; Liu Z; Xu S; Zhang Y; Hu Y; Liu J; Wang D; Huang X
    Int J Nanomedicine; 2019; 14():3221-3234. PubMed ID: 31123399
    [No Abstract]   [Full Text] [Related]  

  • 15. Protective role of antibodies induced by Brucella melitensis B115 against B. melitensis and Brucella abortus infections in mice.
    Adone R; Francia M; Pistoia C; Petrucci P; Pesciaroli M; Pasquali P
    Vaccine; 2012 Jun; 30(27):3992-5. PubMed ID: 22521283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of immunogenicity and protective activity in BALB/c mice of the 25-kDa major outer-membrane protein of Brucella melitensis (Omp25) expressed in Escherichia coli.
    Bowden RA; Cloeckaert A; Zygmunt MS; Dubray G
    J Med Microbiol; 1998 Jan; 47(1):39-48. PubMed ID: 9449948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo immunogenicity assessment and vaccine efficacy evaluation of a chimeric tandem repeat of epitopic region of OMP31 antigen fused to interleukin 2 (IL-2) against Brucella melitensis in BALB/c mice.
    Nazifi N; Tahmoorespur M; Sekhavati MH; Haghparast A; Behroozikhah AM
    BMC Vet Res; 2019 Nov; 15(1):402. PubMed ID: 31703683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous immunization with a novel immunogenic candidate (urease) confers protection against Brucella abortus and Brucella melitensis infections.
    Abkar M; Amani J; Sahebghadam Lotfi A; Nikbakht Brujeni G; Alamian S; Kamali M
    APMIS; 2015 Aug; 123(8):667-75. PubMed ID: 25939375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization and evaluation of a chitosan-coated PLGA nanocarrier for mucosal delivery of Porphyromonas gingivalis antigens.
    da Silva AF; Gonçalves LMD; Fernandes A; Almeida AJ
    Eur J Pharm Sci; 2024 Nov; 202():106896. PubMed ID: 39250981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis.
    Cloeckaert A; Jacques I; Grilló MJ; Marín CM; Grayon M; Blasco JM; Verger JM
    Vaccine; 2004 Jul; 22(21-22):2827-35. PubMed ID: 15246618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.